Federal Capture Intelligence

Top DoD biological product (except diagnostic) manufacturing contractors (NAICS 325414)

Contract actions: October 1, 2021 – September 10, 2026 Updated September 11, 2026 Department of Defense agency guide NAICS 325414 · Biological Product (except Diagnostic) Manufacturing
Latest 12 months
$85.0M
Net obligations · Up $60.8M vs. $24.2M preceding
Prime contractors
18
With positive obligations in the latest 12 months

Research the DoD federal contracting market for biological product (except diagnostic) manufacturing under NAICS 325414. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and potential recompete research leads.

Contract obligation trends for Biological Product (except Diagnostic) Manufacturing at the Department of Defense

Federal records show $3.5B in net obligations across 326 awards in Biological Product (except Diagnostic) Manufacturing at the Department of Defense from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.16% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 251.4% from $24.2M to $85.0M. 3 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $79.5M versus $23.7M through the same date in FY25 (+234.6%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$3.4B126Complete
FY2023−$87.5M109Complete
FY2024$71.3M111Complete
FY2025$29.2M85Complete
FY2026$79.5M54YTD through Sep 10, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$3.5B
326 awards · 56 prime contractors
Latest 12-month movement
+251.4%
$85.0M vs. $24.2M
Leading eight prime share
99.8%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.16% of $2.3T in agency-wide net obligations.
Set-aside share when reported
2.5% of 204 awards with reported set-aside status.
Set-aside reporting
5 set aside · 199 no set-aside · 122 not reported

What changed in the last 12 months?

Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.

Competitive shifts

OCTAPHARMA USA INC gained the most market share
0.4%→10.7%+10.3 percentage points
The contractor now ranks #4 by positive obligations, based on 5 reported actions.
SANOFI VACCINES US INC. lost the most market share
67.2%→11.0%−56.2 percentage points
The contractor now ranks #3 by positive obligations, based on 12 reported actions.

Market structure

This market grew faster than 99.1% of comparable agency NAICS markets
+251.4%Agency median −37.3%
The agency comparison covers 507 comparable NAICS markets.

Buyer demand

Reported obligations through DLA TROOP SUPPORT increased
$21.0M→$74.4M+$53.4M
Latest-period activity spans 16 awards across 4 prime contractors.

Award activity

How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.

87.6% of positive obligations were attributed to DLA TROOP SUPPORT. That represents $74.4M, up $53.4M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. DLA TROOP SUPPORT87.6% · $74.4M · up $53.4M
  2. ARMY MMDA - MM8.4% · $7.1M · up $7.0M
  3. W6DZ CPE CBRND FT DETRICK2.4% · $2.0M · up $2.0M
  4. KIMBROUGH AMB CC MEADE - MM1.1% · $927K · down $852K
  5. NAV MED CTR SAN DIEGO CA - MM0.13% · $113K · up $113K
  6. All other reported offices0.45% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    DLA TROOP SUPPORT

    #1Rank unchanged

    Latest 12 months

    $74.4M

    87.6% of positive obligations

    Versus preceding 12 months

    +$53.4M

    4 active prime contractors · 16 awards

    View office comparison and evidence

    Reported obligations increased 253.7% from $21.0M to $74.4M. The office’s share of positive obligations moved from 87.0% to 87.6%, a change of +0.6 percentage points.

    The latest period contains 18 actions across 16 awards and 2 newly active prime contractors. The preceding period contained 2 active prime contractors and 18 awards.

    Leading award-level changes

  2. Reported funding office

    ARMY MMDA - MM

    #2Up 5 from #7

    Latest 12 months

    $7.1M

    8.4% of positive obligations

    Versus preceding 12 months

    +$7.0M

    1 active prime contractor · 4 awards

    View office comparison and evidence

    Reported obligations increased 7020.0% from $100K to $7.1M. The office’s share of positive obligations moved from 0.41% to 8.4%, a change of +8.0 percentage points.

    The latest period contains 4 actions across 4 awards. The preceding period contained 1 active prime contractor and 1 award.

  3. Reported funding office

    W6DZ CPE CBRND FT DETRICK

    #3New to the positive-obligation ranking

    Latest 12 months

    $2.0M

    2.4% of positive obligations

    Versus preceding 12 months

    +$2.0M

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations moved from $60 in net deobligations to $2.0M in net obligations. The office’s share of positive obligations moved from 0% to 2.4%, a change of +2.4 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 1 active prime contractor and 1 award.

  4. Reported funding office

    KIMBROUGH AMB CC MEADE - MM

    #4Down 2 from #2

    Latest 12 months

    $927K

    1.1% of positive obligations

    Versus preceding 12 months

    −$852K

    1 active prime contractor · 3 awards

    View office comparison and evidence

    Reported obligations decreased 47.9% from $1.8M to $927K. The office’s share of positive obligations moved from 7.4% to 1.1%, a change of −6.3 percentage points.

    The latest period contains 3 actions across 3 awards. The preceding period contained 1 active prime contractor and 2 awards.

    Leading award-level changes

  5. Reported funding office

    NAV MED CTR SAN DIEGO CA - MM

    #5New to the positive-obligation ranking

    Latest 12 months

    $113K

    0.13% of positive obligations

    Versus preceding 12 months

    +$113K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $113K. The office’s share of positive obligations moved from 0% to 0.13%, a change of +0.1 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  6. Reported funding office

    AMC TRIPLER SHAFTER - MM

    #6Down 1 from #5

    Latest 12 months

    $86K

    0.10% of positive obligations

    Versus preceding 12 months

    −$68K

    1 active prime contractor · 3 awards

    View office comparison and evidence

    Reported obligations decreased 44.3% from $154K to $86K. The office’s share of positive obligations moved from 0.64% to 0.10%, a change of −0.5 percentage points.

    The latest period contains 3 actions across 3 awards. The preceding period contained 1 active prime contractor and 7 awards.

  7. Reported funding office

    WALTER REED ARMY INST OF RES - MM

    #7Down 4 from #3

    Latest 12 months

    $70K

    0.080% of positive obligations

    Versus preceding 12 months

    −$308K

    4 active prime contractors · 6 awards

    View office comparison and evidence

    Reported obligations decreased 81.6% from $377K to $70K. The office’s share of positive obligations moved from 1.6% to 0.080%, a change of −1.5 percentage points.

    The latest period contains 8 actions across 6 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 7 awards.

  8. Reported funding office

    633RD MDSS SGSL - MM

    #8New to the positive-obligation ranking

    Latest 12 months

    $41K

    0.050% of positive obligations

    Versus preceding 12 months

    +$41K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $41K. The office’s share of positive obligations moved from 0% to 0.050%, a change of +0.1 percentage points.

    The latest period contains 2 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  9. Reported funding office

    ARMY MED RES INST OF DESEASE - MM

    #9New to the positive-obligation ranking

    Latest 12 months

    $40K

    0.050% of positive obligations

    Versus preceding 12 months

    +$40K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $40K. The office’s share of positive obligations moved from 0% to 0.050%, a change of +0.1 percentage points.

    The latest period contains 4 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  10. Reported funding office

    DLA LAND AND MARITIME (SPE7MX)

    #10New to the positive-obligation ranking

    Latest 12 months

    $36K

    0.040% of positive obligations

    Versus preceding 12 months

    +$36K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $36K. The office’s share of positive obligations moved from 0% to 0.040%, a change of 0.0 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  11. Reported funding office

    DLA AVIATION

    #15Down 7 from #8

    Latest 12 months

    $7K

    0.010% of positive obligations

    Versus preceding 12 months

    −$72K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations decreased 90.6% from $80K to $7K. The office’s share of positive obligations moved from 0.33% to 0.010%, a change of −0.3 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 3 active prime contractors and 3 awards.

  12. Reported funding office

    DLA LAND AND MARITIME (SPE7M1)

    #17Down 11 from #6

    Latest 12 months

    $1

    0% of positive obligations

    Versus preceding 12 months

    −$145K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations decreased 100.0% from $145K to $1. The office’s share of positive obligations moved from 0.60% to 0%, a change of −0.6 percentage points.

    The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 5 awards.

  13. Reported funding office

    DIRECTOR, WRNMMC

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$305K

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $305K to $0. The office’s share of positive obligations moved from 1.3% to 0%, a change of −1.3 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 4 active prime contractors and 5 awards.

Contract types, competition, and procurement methods

From Sep 11, 2025 through Sep 10, 2026, 48 awards had positive obligations totaling $85.0M. Only One Source was the leading reported procedure, accounting for 74.1% of positive obligations. Awards with a reported parent IDV accounted for 99.8%.

Leading award type
99.6%
Delivery Order
Leading reported procedure
74.1%
Only One Source
Reported parent IDV
99.8%
of positive obligations had a reported parent IDV
Median reported offers
1
21 of 48 awards reported offers

Buying method changes

Compared with Sep 11, 2024–Sep 10, 2025. Based on 48 current awards and 59 preceding awards with positive net obligations.

Reported full-and-open obligation share
25.4%
Down from 87.0% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325414 peer median, parent-IDV obligation share is 11.9 percentage points higher, reported full-and-open obligation share is 28.6 percentage points lower, delivery-order obligation share is 11.6 percentage points higher, and median positive award obligations are 68.2% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share99.8%88.0%+11.9 pts
Reported full-and-open obligation share25.4%53.9%-28.6 pts
Delivery-order obligation share99.6%88.0%+11.6 pts
Median positive award obligations$30K$93K-68.2%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)27$84.6M99.6%
BPA Call(A)5$240K0.28%
Purchase Order(B)15$81K0.10%
Definitive Contract(D)1$49K0.060%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)27$84.6M99.6%
BPA(E)5$240K0.28%
Not reported16$131K0.15%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)32$84.8M99.8%
Not reported16$131K0.15%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Only One Source(SSS)12$63.0M74.1%
Negotiated Proposal/Quote(NP)11$21.5M25.4%
Simplified Acquisition(SP1)18$464K0.55%
Sp1(SIMPLIFIED ACQUISITION)7$3K0%

Extent competed

Reported valueAwardsPositive obligationsShare
Not Available for Competition(B)7$62.0M73.0%
Full and Open Competition(A)11$21.5M25.4%
Not Competed(C)5$956K1.1%
Not Competed Under SAP(G)9$271K0.32%
Competed Under SAP(F)9$193K0.23%
G(NOT COMPETED UNDER SAP)6$3K0%
Other reported values1$2440.0003%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Not reported48$85.0M100.0%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)12$63.0M74.1%
SAP Non-Competition (FAR 13)(SP2)15$274K0.32%
Not reported21$21.7M25.6%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)41$85.0M100.0%
J(FIRM FIXED PRICE)7$3K0%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Drugs and Biologicals(6505)23$74.7M88.0%
Medical and Surgical Instruments, Equipment, and Supplies(6515)6$9.2M10.8%
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)13$946K1.1%
Laboratory Equipment and Supplies(6640)2$54K0.060%
Blood and Blood Products(6506)1$49K0.060%
Maint/Repair/Rebuild of Equipment- Instruments and Laboratory Equipment(J066)1$15K0.020%
Other reported values2$21K0.024%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Defense Logistics Agency(97AS)27$74.5M87.7%
Defense Health Agency(97DH)16$9.5M11.2%
Department of the Army(2100)4$957K1.1%
Department of the Navy(1700)1$15K0.020%

Awarding offices

Reported valueAwardsPositive obligationsShare
Dla Troop Support(SPE2DP)15$74.4M87.6%
Army Med Res Acq Activity(HT9425)3$5.4M6.4%
Defense Health Agency(HT9427)2$3.7M4.4%
W40m Usa Hca(W81K04)3$927K1.1%
Defense Health Agency(HT9426)4$117K0.14%
Defense Health Agency Hcd West(HT9410)1$113K0.13%
Other reported values20$264K0.31%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
SPE2DP26D0001(9700)2$52.9M62.2%
SPE2DP26D0006(9700)1$10.7M12.6%
HT942525DE004(9700)5$9.1M10.7%
SPE2DP26D0004(9700)4$8.7M10.3%
SPE2DP26D0005(9700)1$1.5M1.8%
W81K0425DA010(9700)3$927K1.1%
SPE2DP26D0003(9700)5$591K0.70%
HT941025A0002(9700)1$113K0.13%
Other reported values10$253K0.30%
Not reported16$131K0.15%

Offers, award size, and timing

Median reported offers
1 median
21 reported · 27 not reported
Positive award obligations
$30K median
$2K–$824K middle 50%
Reported performance period
119 days (~4 months) median
48 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
3 of 18prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
62.3%of positive obligations in the last 12 months
Leading four prime contractors
98.3%of positive obligations in the last 12 months
Leading eight prime contractors
99.8%of positive obligations in the last 12 months

Based on $85.0M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $52.9M

    62.3%

    Dollar movement

    +$52.9M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for MERIDIAN MEDICAL TECHNOLOGIES, LLC
    Obligations: prior → latest
    $0 → $52.9M
    Not comparable
    Share: prior → latest
    0% → 62.3%
    +62.3 percentage points
    All-period obligations
    $52.9M
    1.5% of all-period positive obligations · 5 awards
    Recorded activity
    Since Oct 21, 2021
    through Apr 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported20
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $12.2M

    14.4%

    Dollar movement

    +$7.4M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for SEQIRUS USA INC
    Obligations: prior → latest
    $4.8M → $12.2M
    +154.6%
    Share: prior → latest
    19.8% → 14.4%
    −5.5 percentage points
    All-period obligations
    $72.8M
    2.1% of all-period positive obligations · 18 awards
    Recorded activity
    Since Nov 24, 2021
    through Feb 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported23
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $9.3M

    11.0%

    Dollar movement

    −$6.9M

    vs. prior 12 months

    Last 12mo awards

    11 awards

    12 actions

    Historical and award details for SANOFI VACCINES US INC.
    Obligations: prior → latest
    $16.2M → $9.3M
    −42.6%
    Share: prior → latest
    67.2% → 11.0%
    −56.2 percentage points
    All-period obligations
    $35.2M
    1.0% of all-period positive obligations · 42 awards
    Recorded activity
    Since Nov 24, 2021
    through Apr 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside20
    Not reported915
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $9.1M

    10.7%

    Dollar movement

    +$9.0M

    vs. prior 12 months

    Last 12mo awards

    5 awards

    5 actions

    Historical and award details for OCTAPHARMA USA INC
    Obligations: prior → latest
    $100K → $9.1M
    +9020.0%
    Share: prior → latest
    0.41% → 10.7%
    +10.3 percentage points
    All-period obligations
    $9.2M
    0.26% of all-period positive obligations · 6 awards
    Recorded activity
    Since May 23, 2025
    through Mar 4, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported50
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $927K

    1.1%

    Dollar movement

    −$852K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    3 actions

    Historical and award details for GREER LABORATORIES, INC.
    Obligations: prior → latest
    $1.8M → $927K
    −47.9%
    Share: prior → latest
    7.4% → 1.1%
    −6.3 percentage points
    All-period obligations
    $2.7M
    0.080% of all-period positive obligations · 5 awards
    Recorded activity
    Since Jun 6, 2025
    through Apr 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported32
    Reported small business32
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $199K

    0.23%

    Dollar movement

    +$29K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    4 actions

    Historical and award details for PROLACTA BIOSCIENCE, INC
    Obligations: prior → latest
    $170K → $199K
    +16.9%
    Share: prior → latest
    0.70% → 0.23%
    −0.5 percentage points
    All-period obligations
    $3.5M
    0.10% of all-period positive obligations · 39 awards
    Recorded activity
    Since Nov 9, 2021
    through Apr 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside49
    Not reported00
    Reported small business02
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $42K

    0.050%

    Dollar movement

    +$42K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for ZEN-BIO, INC.
    Obligations: prior → latest
    $0 → $42K
    Not comparable
    Share: prior → latest
    0% → 0.050%
    +0.1 percentage points
    All-period obligations
    $145K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Jun 2, 2022
    through Mar 30, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside20
    Not reported00
    Reported small business20
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $41K

    0.050%

    Dollar movement

    +$41K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for AMERICAN NATIONAL RED CROSS, THE
    Obligations: prior → latest
    $0 → $41K
    Not comparable
    Share: prior → latest
    0% → 0.050%
    +0.1 percentage points
    All-period obligations
    $2.0M
    0.060% of all-period positive obligations · 7 awards
    Recorded activity
    Since Nov 2, 2021
    through Feb 10, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $40K

    0.050%

    Dollar movement

    +$40K

    vs. prior 12 months

    Last 12mo awards

    1 award

    4 actions

    Historical and award details for KEMP PROTEINS, LLC
    Obligations: prior → latest
    $0 → $40K
    Not comparable
    Share: prior → latest
    0% → 0.050%
    +0.1 percentage points
    All-period obligations
    $40K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 22, 2025
    through Jan 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported10
    Reported small business10
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $36K

    0.040%

    Dollar movement

    −$109K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for BNB PLUS CORP.
    Obligations: prior → latest
    $145K → $36K
    −75.0%
    Share: prior → latest
    0.60% → 0.040%
    −0.6 percentage points
    All-period obligations
    $614K
    0.020% of all-period positive obligations · 18 awards
    Recorded activity
    Since Dec 7, 2021
    through Dec 15, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported25
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $30K

    0.030%

    Dollar movement

    +$724

    vs. prior 12 months

    Last 12mo awards

    1 award

    4 actions

    Historical and award details for LIFESTREAM BLOOD BANK
    Obligations: prior → latest
    $29K → $30K
    +2.5%
    Share: prior → latest
    0.12% → 0.030%
    −0.1 percentage points
    All-period obligations
    $81K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Oct 26, 2021
    through Jan 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $29K

    0.030%

    Dollar movement

    +$29K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for INSTRUMENTATION LABORATORY S.P.A.
    Obligations: prior → latest
    $0 → $29K
    Not comparable
    Share: prior → latest
    0% → 0.030%
    0.0 percentage points
    All-period obligations
    $29K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Apr 9, 2026
    through Apr 16, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported10
    Reported small business00
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $16K

    0.020%

    Dollar movement

    −$16K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for LGC CLINICAL DIAGNOSTICS INC
    Obligations: prior → latest
    $31K → $16K
    −50.0%
    Share: prior → latest
    0.13% → 0.020%
    −0.1 percentage points
    All-period obligations
    $47K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 27, 2024
    through Sep 25, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $15K

    0.020%

    Dollar movement

    −$40K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for LIFE TECHNOLOGIES CORPORATION
    Obligations: prior → latest
    $56K → $15K
    −72.3%
    Share: prior → latest
    0.23% → 0.020%
    −0.2 percentage points
    All-period obligations
    $249K
    0.010% of all-period positive obligations · 16 awards
    Recorded activity
    Since Oct 5, 2021
    through Dec 3, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside27
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $15K

    0.020%

    Dollar movement

    +$336

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for LAMPIRE BIOLOGICAL LABS INC
    Obligations: prior → latest
    $14K → $15K
    +2.3%
    Share: prior → latest
    0.060% → 0.020%
    0.0 percentage points
    All-period obligations
    $76K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Dec 2, 2021
    through Mar 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business11
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

MERIDIAN MEDICAL TECHNOLOGIES, LLC

8512025830!ANTIDOTE TREATMENT

The reported potential end date is Jan 7, 2027. Current award value is 100.0% of reported potential value ($36.5M of $36.5M).

Performance period

56.7%

As of Sep 10, 2026Potential end Jan 7, 2027

Current award value as a share of potential value

100.0%

$36.5M current$36.5M potential
Supporting data

Reported performance starts Apr 7, 2026.

No later potential end date is reported; current and potential end dates are both Jan 7, 2027.

$36.5M is obligated against $36.5M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID SPE2DP26F4183

These are research leads, not confirmed recompetes. USAspending records through Sep 10, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Base award

This action

+$36.5M

MERIDIAN MEDICAL TECHNOLOGIES, LLC

DLA TROOP SUPPORT

8512025830!ANTIDOTE TREATMENT

Why it stands out

One action equaled more than a third of the market’s latest 12-month positive obligations.

The $36.5M action represented 42.9% of the market’s positive obligations over the latest 12 months.

Award net obligations
$36.5M
Share of 12-month positive obligations
42.9%
Supporting data
Prime contractor
#1 · 62.3% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#1 · 87.6% attributed share
+0.6 percentage points · $53.4M net increase; action accounted for 68.3%
Related:Funding office gainUnusually large action
PIID SPE2DP26F4183
Base award

This action

+$10.7M

SEQIRUS USA INC

DLA TROOP SUPPORT

8511922204!INFLUENZA VIRUS VAC

Why it stands out

One action represented 12.6% of the market’s latest 12-month positive obligations.

At $10.7M, the action was large enough to materially affect the latest 12-month market picture.

Award net obligations
$10.7M
Share of 12-month positive obligations
12.6%
Supporting data
Prime contractor
#2 · 14.4% share
−5.5 percentage points · $7.4M net increase; action exceeded it by $3.3M
PIID SPE2DP26F2834
Base award

This action

+$16.4M

MERIDIAN MEDICAL TECHNOLOGIES, LLC

DLA TROOP SUPPORT

8511797933!ANTIDOTE TREATMENT

Why it stands out

One action represented 19.3% of the market’s latest 12-month positive obligations.

At $16.4M, the action was large enough to materially affect the latest 12-month market picture.

Award net obligations
$16.4M
Share of 12-month positive obligations
19.3%
PIID SPE2DP26F1088
Base award

This action

+$2.0M

OCTAPHARMA USA INC

W6DZ CPE CBRND FT DETRICK

FIRST TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE.

Why it stands out

The contractor climbed 4 positions in this market.

It now ranks #4 by positive obligations over the latest 12 months.

Award net obligations
$2.0M
Share of 12-month positive obligations
2.4%
Supporting data
Prime contractor
#4 · 10.7% share
up 4 ranks · +10.3 percentage points · $9.0M net increase; action accounted for 22.2%
Funding office
#3 · 2.4% attributed share
+2.4 percentage points · $2.0M net increase; action accounted for 100.0%
Related:Largest share gain
PIID HT942525FE059
Base award

This action

+$3.0M

SANOFI VACCINES US INC.

DLA TROOP SUPPORT

8511928943!INFLUENZA VIRUS VAC

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 3.5% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $6.9M overall.

Award net obligations
$3.0M
Share of 12-month positive obligations
3.5%
Supporting data
Prime contractor
#3 · 11.0% share
$6.9M net decline despite this positive action
PIID SPE2DP26F2910
Base award

This action

+$470K

GREER LABORATORIES, INC.

KIMBROUGH AMB CC MEADE - MM

ALLERGEN EXTRACT SUPPLIES

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 0.55% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $852K overall.

Award net obligations
$470K
Share of 12-month positive obligations
0.55%
Supporting data
Prime contractor
#5 · 1.1% share
$852K net decline despite this positive action
Funding office
#4 · 1.1% attributed share
$852K net decline despite this positive action
PIID W81K0426FA037
View recent award activity by date (10)
  1. UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.Base award · PIID HT942626FE037
    Action+$13K
    Award net obligations$13K
  2. PROLACTA BIOSCIENCE, INCBase award · PIID HT941026FE035
    Action+$113K
    Award net obligations$113K
  3. INSTRUMENTATION LABORATORY S.P.A.Base award · PIID HT940626FE042
    Action+$29K
    Award net obligations$29K
  4. GREER LABORATORIES, INC.Base award · PIID W81K0426FA193
    Action+$455K
    Award net obligations$455K
  5. MERIDIAN MEDICAL TECHNOLOGIES, LLCBase award · PIID SPE2DP26F4183
    Action+$36.5M
    Award net obligations$36.5M
  6. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F4178
    Action+$3K
    Award net obligations$3K
  7. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F4066
    Action+$2K
    Award net obligations$2K
  8. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F3981
    Action+$87K
    Award net obligations$87K
  9. BIOMERIEUX INCBase award · PIID SPE2DS26P1391
    Action+$489
    Award net obligations$489
  10. ZEN-BIO, INC.Modification · PIID HT942626CE004
    Action+$6K
    Award net obligations$49K

DoD biological product (except diagnostic) manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top DoD biological product (except diagnostic) manufacturing contractors?

In the 12 months through September 10, 2026, MERIDIAN MEDICAL TECHNOLOGIES, LLC, SEQIRUS USA INC, and SANOFI VACCINES US INC. were the leading DoD biological product (except diagnostic) manufacturing prime contractors by positive obligations.

  1. #1

    MERIDIAN MEDICAL TECHNOLOGIES, LLC

    $52,881,500 in positive obligations

  2. #2

    SEQIRUS USA INC

    $12,212,593 in positive obligations

  3. #3

    SANOFI VACCINES US INC.

    $9,327,594 in positive obligations

Rankings use reported USAspending award data.

Did DoD contract obligations increase in the biological product (except diagnostic) manufacturing market?

Yes. Measured by net prime contract obligations, reported DoD activity in the biological product (except diagnostic) manufacturing market increased 251.4% from $24,176,645 in the preceding 12 months to $84,951,065 in the 12 months through September 10, 2026.

Latest 12 months
$84,951,065
Net prime contract obligations
Preceding 12 months
$24,176,645
Net prime contract obligations
Change
+251.4%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent DoD contract award activity was reported in the biological product (except diagnostic) manufacturing market?

Recent DoD contract award activity reported in the biological product (except diagnostic) manufacturing market included actions for MERIDIAN MEDICAL TECHNOLOGIES, LLC, SEQIRUS USA INC, and OCTAPHARMA USA INC during the 12 months through September 10, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for DoD contracts under NAICS 325414?

From September 11, 2025 through September 10, 2026, DoD reported 48 positive-obligation awards for biological product (except diagnostic) manufacturing under NAICS 325414. The leading award type was delivery order. The leading reported procedure was only one source.

Positive-obligation awards
48
Leading reported procedure
Only One Source
74.1% of positive obligations
Leading award type
Delivery Order
99.6% of positive obligations
Full and open
25.4%
of positive obligations
Reported parent IDV
99.9%
of positive obligations

Percentages use positive obligations as the denominator.

Which DoD biological product (except diagnostic) manufacturing awards may warrant recompete research?

Based on its reported potential-end date, the DoD biological product (except diagnostic) manufacturing award held by MERIDIAN MEDICAL TECHNOLOGIES, LLC may warrant recompete research.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.

Review data methodology